Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07538466 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 20, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Addpharma Inc.
28 trials monitored
See 1 trial at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232
Trial Details
NCT Number NCT07538466
Lead Sponsor Addpharma Inc.
Conditions
(from sponsor)		 Diabetes Mellitus
Related terms Diabetes Mellitus
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov